ReviewEuropean respiratory review : an official journal of the European Respiratory Society2026
Frailty and COPD: a bidirectional relationship in the context of systemic and accelerated ageing.
Review in European respiratory review : an official journal of the European Respiratory Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic obstructive pulmonary disease (COPD) is increasingly recognised as a systemic disorder that extends beyond the lungs, representing a clinical model of accelerated ageing. Frailty, a multidimensional syndrome characterised by reduced physiological reserve and increased vulnerability to stressors, is highly prevalent among individuals with COPD and contributes to adverse outcomes. Both conditions share common biological mechanisms, including chronic inflammation, oxidative stress, endocrine dysregulation, mitochondrial dysfunction and skeletal muscle atrophy. Exercise acts as a physiological stressor that elicits hormetic responses, triggering favourable molecular adaptations such as enhanced mitochondrial biogenesis, improved redox balance and the upregulation of antioxidant and cellular repair pathways. These adaptations translate into improved muscle function, metabolic efficiency and immune homeostasis, thereby counteracting the catabolic processes that underlie both frailty and COPD progression. Scientific evidence supports the role of combined aerobic, resistance and balance training as the most effective approach to improving functional status and quality of life in frail individuals with COPD. Frailty in COPD represents a potentially reversible state of systemic vulnerability rooted in accelerated biological ageing. Exercise thus constitutes a powerful, multi-target intervention capable of reprogramming molecular ageing pathways and promoting resilience across organ systems. Integrating exercise physiology with the principles of geroscience offers a promising framework for personalised rehabilitation strategies aimed at extending health span in patients with COPD. This narrative review summarises current evidence on the biological and clinical interplay between COPD, frailty and exercise, exploring how physical activity exerts systemic anti-ageing effects through modulation of inflammation, oxidative stress, mitochondrial and myokine signalling, ultimately restoring physiological resilience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.